Analysis of Circulating Tumor Markers in Blood

Launched by INSTITUT DU CANCER DE MONTPELLIER - VAL D'AURELLE · Jul 16, 2019

Keywords

ClinConnect Summary

This clinical trial is studying the use of blood tests to find specific markers that can indicate the presence of cancer and help doctors understand how well certain treatments might work. These markers are substances that come from cancer cells and are found in the blood. Researchers hope that by analyzing these markers, they can improve cancer diagnosis and treatment planning for patients.

To participate in this trial, you need to be an adult (18 years or older) who has been diagnosed or is suspected of having cancer, regardless of where it is in your body. You will need to give your consent before any tests are done. However, if you are unable to participate due to certain conditions—like if you are pregnant, breastfeeding, or unable to attend follow-up appointments—then you may not be eligible. If you join the study, you will help researchers learn more about these blood markers, which could lead to better cancer care in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Patient presenting an invasive tumoral pathology (proved or suspected), whatever is the location or the stage,
• • 2. Man or woman ≥ 18 years,
• • 3. Obtaining of the informed consent signed before any procedure of specific preselection on approval.
• Exclusion Criteria:
• • 1. Private persons of freedom or under guardianship,
• • 2. Patient whose regular follow-up is impossible for psychological, family, social or geographical reasons,
• • 3. Pregnant woman and/or breast-feeding,
• • 4. Unaffiliated patient to Social Protection System,